Literature DB >> 5844404

Aplastic anemia induced by quinacrine.

L Biro, N Leone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5844404

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  7 in total

1.  The quinacrine experience in a population of patients with cutaneous lupus erythematosus and dermatomyositis.

Authors:  Lavanya Mittal; Victoria P Werth
Journal:  J Am Acad Dermatol       Date:  2017-08       Impact factor: 11.527

2.  Marrow transplantation for severe aplastic anemia associated with exposure to quinacrine.

Authors:  I Schmid; C Anasetti; F B Petersen; R Storb
Journal:  Blut       Date:  1990 Aug-Sep

Review 3.  Treatment of cutaneous lupus.

Authors:  Aileen Y Chang; Victoria P Werth
Journal:  Curr Rheumatol Rep       Date:  2011-08       Impact factor: 4.592

Review 4.  New hopes from old drugs: revisiting DNA-binding small molecules as anticancer agents.

Authors:  Katerina Gurova
Journal:  Future Oncol       Date:  2009-12       Impact factor: 3.404

5.  Antimalarial drug toxicities in patients with cutaneous lupus and dermatomyositis: A retrospective cohort study.

Authors:  Lavanya Mittal; Lingqiao Zhang; Rui Feng; Victoria P Werth
Journal:  J Am Acad Dermatol       Date:  2017-10-06       Impact factor: 11.527

6.  Beyond DNA binding - a review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancers.

Authors:  Reza Ehsanian; Carter Van Waes; Stephan M Feller
Journal:  Cell Commun Signal       Date:  2011-05-15       Impact factor: 5.712

7.  Prescription strategy of antimalarials in cutaneous and systemic lupus erythematosus: an international survey.

Authors:  Arthur Petitdemange; Renaud Felten; Jean Sibilia; Thierry Martin; Laurent Arnaud
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-05-19       Impact factor: 5.346
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.